Sign in
4

Changes in Ownership

MBX Biosciences, Inc. Filed Acc 0001193125-26-107268

President & CEO bought 18,500 shares at $28.41 ($525,663)

From the SEC's structured data for this filing

Trades in this filing

Hawryluk P. Kent · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-13 Purchase : show line 1 in the form +18,500 $28.41 $525,663 486,777 I
Open-market purchases · 18,500 sh · avg $28.41 · $525,663
Loading xslF345X05/ownership.xml…